跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACE2-M
首页
药物
ACE2-M
ACE2-M
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of forsythiaside H in preparation of anti-coronavirus products
申请人: UNIV CAPITAL MEDICAL SCIENCES
优先权: 2020
CN
Application of forsythiaside A in preparation of anti-coronavirus products
申请人: UNIV CAPITAL MEDICAL SCIENCES
优先权: 2020
CN
CORONAVIRUS-DERIVED RECEPTOR BINDING DOMAIN VARIANT WITH REDUCED ACE2 BINDING CAPACITY, AND VACCINE COMPOSITION COMPRISING SAME
申请人: GI CELL INC
优先权: 2020
EP
SARS-CoV virus structural protein infusion protein and its high yield expression and purification and uses
申请人: INST BASIC MED SCIENCES PLA
优先权: 2005
CN
Biosensing platform for detecting viral infections and methods for screening a modulator of viral infections and protecting therefrom
申请人: PIN JYE BIO TECH CO LTD
优先权: 2021
US
HACE2 knocked-in stem cells with novel coronavirus RNA interference
申请人: WENG BINGHUAN
优先权: 2020
CN
Polypeptide TG-28 and application thereof
申请人: CHENGDU PEIDE BIOLOGICAL MEDICINE CO LTD
优先权: 2021
CN
Genetically modified stem cells for treating COVID-19
申请人: WENG BINGHUAN
优先权: 2020
CN
药物
反馈